Data Collection Study Using CS BP Pillow System (NCT07635602) | Clinical Trial Compass
CompletedNot Applicable
Data Collection Study Using CS BP Pillow System
United States40 participantsStarted 2026-02-10
Plain-language summary
Collect raw data from CS BP Pillow System and Arterial line (A-line) in volunteers. The data collected in the study will be used for development of the CS BP algorithm.
Who can participate
Age range
40 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 40-80 years old.
* Ability and willingness to sign and understand an informed consent form.
* The participant has a palpable radial pulse in both wrists.
* The participant is willing and able to be fitted with the investigational device, A-line, and reference cuff, and is willing and able to undergo all study procedures, including 1 hour of recording with the investigational device and A-line.
Exclusion Criteria:
* Participant who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the participant or interfere with the data collected.
* Participant whose body habitus precludes them from wearing the investigational device on their wrist.
* Female participants who self-reported as pregnant based on a urine pregnancy test, or who are self-reported as trying to get pregnant or who are breastfeeding.
* Participant whose BMI is greater than 35.
* Participant with a documented medical history of cardiac arrhythmia.
* Participant with diagnosed diabetes mellitus.
* Participant with implanted cardiac defibrillators or pacemakers, Ventricular Assist Device (VAD) or other mechanical circulatory support devices, whether intracorporal or extracorporeal.
* Participant with stage 4 or stage 5 end-stage renal disease, or participants with arteriovenous shunts.
* Participant with pheochromocytoma or primary hyperaldosteronism.
* Participant with diagnosed heart failure with New York Heart Association (NYHA)…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of subjects with complete protocol-defined multi-modal physiological signal acquisition